logo
Sign in

NVNO Stock Price, Chart, Stats & News

enVVeno Medical Corporation
Save
160,081
Market cap
Current P/E
Forward P/E

NVNO chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
Operating margin
Pretax margin
Net margin
Effective tax rate
ROA
-65.87%
ROE
-60.88%
D/E
0.03x
Interest coverage ratio

NVNO valuation

P/E
P/S
P/B
0.23x
P/CF
-0.40x
P/FCF
-0.01x
P/OCF
-0.40x
PEG
-0.01x
EV multiple
-0.13x

About

enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency.

Similar securities

Based on sector and market capitalization

Report issue